share_log

和鉑醫藥-B：截至二零二四年一月三十一日止之股份發行人的證券變動月報表

HBM HOLDINGS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 5 03:52
Summary by Moomoo AI
和鉑醫藥控股有限公司（和铂医药-B）於2024年2月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年1月31日的情況。報告顯示，公司的法定/註冊股本在本月內無變動，結存總數維持在20,000,000,000股，每股面值0.000025美元，總額為500,000美元。此外，公司的股份期權計劃在本月內有所變動，首次公開發售後購股權計劃的股份期權數目由上月底的38,187,950增加至39,250,950，主要是因為有234,000股份期權失效。公司亦進行了股份回購，共計1,750,000股，於2023年6月8日完成。根據報告，所有證券變動均已獲得董事會的正式授權，並符合相關法律規定。
和鉑醫藥控股有限公司（和铂医药-B）於2024年2月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年1月31日的情況。報告顯示，公司的法定/註冊股本在本月內無變動，結存總數維持在20,000,000,000股，每股面值0.000025美元，總額為500,000美元。此外，公司的股份期權計劃在本月內有所變動，首次公開發售後購股權計劃的股份期權數目由上月底的38,187,950增加至39,250,950，主要是因為有234,000股份期權失效。公司亦進行了股份回購，共計1,750,000股，於2023年6月8日完成。根據報告，所有證券變動均已獲得董事會的正式授權，並符合相關法律規定。
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 FEBRUARY 2024 COVERING THE SITUATION AS OF 31 JANUARY 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding amount of 20,000,000,000 shares with a face value of $0.000025 per share, totaling $500,000. In addition, the Company's stock option plan changed during the month, with the number of stock options under the Initial Public Offering Option Plan increasing from 38,187,950 at the end of last month to 39,250,950, primarily due to the expiration of 234,000 share options. The company also carried out a share repurchase totaling 1,750,000 shares, which was completed on June 8, 2023. According to the report, all securities movements have been formally authorized by the Board of Directors and comply with relevant legal requirements.
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 5 FEBRUARY 2024 COVERING THE SITUATION AS OF 31 JANUARY 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding amount of 20,000,000,000 shares with a face value of $0.000025 per share, totaling $500,000. In addition, the Company's stock option plan changed during the month, with the number of stock options under the Initial Public Offering Option Plan increasing from 38,187,950 at the end of last month to 39,250,950, primarily due to the expiration of 234,000 share options. The company also carried out a share repurchase totaling 1,750,000 shares, which was completed on June 8, 2023. According to the report, all securities movements have been formally authorized by the Board of Directors and comply with relevant legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more